drugset / Trial / NCT00886366

Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

NCT00886366 ↗

Phase 1 Terminated 26 enrolled AstraZeneca
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to assess safety and tolerability of AZD6714 after single ascending oral doses in healthy male subjects and type 2 diabetic patients.

Timeline

Start
2009-04
Primary completion
2009-09
Completion
2009-09

Outcome

Outcome not reported

Stopped: “Part A reached a predefined stopping criteria. Relevant doses for part B could not be established based on A and subsequently study was stopped.”

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD6714 Unknown — Oral